Table.
Stages in handling of new technologies
Stage | Purpose | Examples |
---|---|---|
Primary research | To support licensing and marketing decisions | Trials sponsored by pharmaceutical companies |
Research (often case series) sponsored by other manufacturers | ||
Brief report by an NHS agency or independent agent | To give early advice on use of technology | National Prescribing Centre bulletin |
HTA programme briefings or vignettes5 | ||
Editorials in medical journals | ||
Drugs and Therapeutics Bulletin reports9 | ||
Rapid and rigorous systematic review | To support timely guidance and guidelines (for example, from the National Institute for Clinical Excellence) | Development and Evaluation Systems reports |
Assessments externally commissioned by NICE | ||
Longer term systematic review | To bring together all high quality evidence about effects, costs, and broader impact of technology | Products of Cochrane Collaboration |
Reviews commissioned by NHS Health Technology Assessment Programme | ||
Pragmatic randomised controlled trial | To provide more definitive answers to the question: “For whom does it work, and is it worth it in practice?” | Occasionally funded by NHS Health Technology Assessment Programme, by other research and development programmes, by the Medical Research Council |